Doxacurium vs. Pancuronium. [electronic resource]
- Critical care medicine Feb 1996
- 366-7 p. digital
Publication Type: Letter; Comment
0090-3493
10.1097/00003246-199602000-00036 doi
Cost-Benefit Analysis Drug Costs Humans Intensive Care Units Isoquinolines--economics Neuromuscular Nondepolarizing Agents--economics Pancuronium--economics